# Pharmacokinetic and Safety Trial of Intravenous Levetiracetam in the Treatment of Neonatal Seizures

> **NCT00884052** · PHASE1,PHASE2 · COMPLETED · sponsor: **Richard H. Haas** · enrollment: 18 (actual)

## Conditions studied

- Seizures
- Disorder of Fetus or Newborn

## Interventions

- **DRUG:** Low dose levetiracetam
- **DRUG:** High dose levetiracetam

## Key facts

- **NCT ID:** NCT00884052
- **Lead sponsor:** Richard H. Haas
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2011-03
- **Final completion:** 2011-10
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2020-03-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00884052

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00884052, "Pharmacokinetic and Safety Trial of Intravenous Levetiracetam in the Treatment of Neonatal Seizures". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00884052. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*